Literature DB >> 19320704

From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain.

Nuria Romo1, Mónica Poo, Rosario Ballesta.   

Abstract

INTRODUCTION AND AIMS: In recent decades, studies have been made of the possible benefits of treatments using heroin, although qualitative methodologies have not usually been employed. In 2004, in Granada (Spain), a clinical experiment was launched: the Experimental Narcotics Prescription Programme in Andalusia (PEPSA). This project attempted to evaluate the effectiveness of intravenous heroin and orally-administered methadone prescription for long-term socially-excluded opiate addicts for whom other treatments have failed. The research described herein is qualitative and has been carried out within the framework of the aforementioned experiment. The objective was to discover the attitudes, opinions and experiences of patients (and relatives) once they had been included in the program and are receiving heroin in a therapeutic environment. DESIGN AND METHODS: Focused ethnographic procedures were used to establish the study population. During the field work, we carried out in-depth interviews and observations using 21 patients and relatives. Analysis was carried out by a team according to grounded theory.
RESULTS: Our results show how the treatment process and the administering of heroin in a therapeutic context manages to break the habit of consuming heroin obtained illegally, thus changing the significance given to the substance and bringing about improvements in aspects such as the workplace, family relations and physical and mental health. DISCUSSION AND
CONCLUSIONS: The move from 'substance addiction' to chronic 'illness' upon beginning the treatment provides a chance for a population with a long history of rejection and exclusion to become part of society once again.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320704     DOI: 10.1111/j.1465-3362.2008.00015.x

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  6 in total

1.  Heroin: from drug to ambivalent medicine : on the introduction of medically prescribed heroin and the emergence of a new space for treatment.

Authors:  Birgitte Schepelern Johansen; Katrine Schepelern Johansen
Journal:  Cult Med Psychiatry       Date:  2015-03

Review 2.  Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.

Authors:  James Bell; Vendula Belackova; Nicholas Lintzeris
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

3.  What can qualitative research do for randomised controlled trials? A systematic mapping review.

Authors:  A O'Cathain; K J Thomas; S J Drabble; A Rudolph; J Hewison
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

4.  A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.

Authors:  Eugenia Oviedo-Joekes; Kirsten Marchand; Kurt Lock; Jill Chettiar; David C Marsh; Suzanne Brissette; Aslam H Anis; Martin T Schechter
Journal:  Addict Sci Clin Pract       Date:  2014-09-29

5.  Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.

Authors:  Heather Palis; Kirsten Marchand; Daphne Guh; Suzanne Brissette; Kurt Lock; Scott MacDonald; Scott Harrison; Aslam H Anis; Michael Krausz; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-05-19

6.  Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.

Authors:  Kirsten Marchand; Julie Foreman; Scott MacDonald; Scott Harrison; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.